This grant is for advancing behavioral intervention development research, encompassing efficacy testing, clinical trials, and examining mechanisms of behavior change. It supports optimizing treatment dose-response and sequencing behavioral, combined, or integrated behavioral and pharmacological interventions. Key areas of focus include drug abuse treatment for patients with comorbidities, enhancing treatment adherence, and leveraging technology for improved implementation. The program also funds interventions to prevent HIV acquisition/transmission among individuals in drug abuse treatment, promote adherence to various medications, and address substance misuse alongside chronic pain. Research at Stage I and beyond is encouraged.
Opportunity ID: 358369
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-24-300 |
| Funding Opportunity Title: | Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.273 — Alcohol Research Programs |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jan 22, 2025 |
| Last Updated Date: | Jan 22, 2025 |
| Original Closing Date for Applications: | May 07, 2025 |
| Current Closing Date for Applications: | May 07, 2025 |
| Archive Date: | Jun 12, 2025 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | County governments Native American tribal governments (Federally recognized) Private institutions of higher education Special district governments Others (see text field entitled “Additional Information on Eligibility” for clarification) Small businesses Independent school districts For profit organizations other than small businesses Public and State controlled institutions of higher education Public housing authorities/Indian housing authorities Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education State governments City or township governments Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this funding opportunity announcement (FOA) is to encourage behavioral intervention development research to test efficacy, conduct clinical trials, examine mechanisms of behavior change, determine dose-response, treatment optimization, and/or ascertain best sequencing of behavioral, combined, sequential, or integrated behavioral and pharmacological (1) drug abuse treatment interventions, including interventions for patients with comorbidities; (2) drug abuse treatment and adherence interventions; (3) drug abuse treatment and adherence interventions that utilize technologies to boost effects and increase implementability and sustainability; (4) interventions to prevent the acquisition or transmission of HIV infection among individuals in drug abuse treatment; (5) interventions to promote adherence to drug abuse treatment, HIV and addiction medications; and (6) interventions to treat substance misuse and chronic pain. Research of interest includes but is not limited to Stage I research. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/pa-files/PAR-24-300.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 358369 Full Announcement-PAR-24-300 -> PAR-24-300-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-I | Use for due dates on or after January 25, 2025 | PKG00290279 | Jan 22, 2025 | May 07, 2025 | View |
Package 1
Mandatory forms
358369 RR_SF424_5_0-5.0.pdf
358369 PHS398_CoverPageSupplement_5_0-5.0.pdf
358369 RR_OtherProjectInfo_1_4-1.4.pdf
358369 PerformanceSite_4_0-4.0.pdf
358369 RR_KeyPersonExpanded_4_0-4.0.pdf
358369 PHS398_ResearchPlan_5_0-5.0.pdf
358369 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
358369 RR_Budget_3_0-3.0.pdf
358369 RR_SubawardBudget30_3_0-3.0.pdf
358369 PHS398_ModularBudget_1_2-1.2.pdf
358369 PHS_AssignmentRequestForm_4_0-4.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
